NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron.
about
Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy.Getting it right the first time: recent progress in optimizing antiemetic usage.A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiEvolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
P2860
NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
NEPA, a fixed oral combination ...... rial versus oral palonosetron.
@en
NEPA, a fixed oral combination ...... rial versus oral palonosetron.
@nl
type
label
NEPA, a fixed oral combination ...... rial versus oral palonosetron.
@en
NEPA, a fixed oral combination ...... rial versus oral palonosetron.
@nl
prefLabel
NEPA, a fixed oral combination ...... rial versus oral palonosetron.
@en
NEPA, a fixed oral combination ...... rial versus oral palonosetron.
@nl
P2093
P2860
P1476
NEPA, a fixed oral combination ...... rial versus oral palonosetron.
@en
P2093
Cristina Oprean
Giada Rizzi
Giorgia Rossi
Lee Schwartzberg
Maria Elisa Borroni
Matti Aapro
Meinolf Karthaus
Servando Cardona-Huerta
Tomasz Sarosiek
P2860
P2888
P304
P356
10.1007/S00520-016-3502-X
P577
2016-11-24T00:00:00Z